University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells

In situ processing by LEAP system to enable novel experiments with

26-Nov-2008 - USA

Cyntellect announced that it has entered a research collaboration agreement with theUniversity of Florida Interdisciplinary Center for biotechnology Research. The agreement will focus on a variety of research areas including the purification and analysis of cancer stem cells (CSCs), rare cells which are believed to be directly involved in propagating cancers. The collaboration will exploit Cyntellect's proprietary LEAP system to purify these CSCs and their progeny without disturbing them from their growing environment - a feat that should improve scientists' ability to study the natural properties and responses of these cells. Under the agreement, University of Florida will gain access to LEAP and Cyntellect will receive certain payments and commercial rights to discoveries under the collaboration.

"We are very pleased to embark with University of Florida on this quest to gain a better understanding of the molecular machinery, signaling pathways and markers associated with rare cells, such as CSCs. This information will be paramount to innovating novel drug development strategies and developing new cutting-edge diagnostics for crippling diseases, such as cancer," stated Dr.Fred Koller, Cyntellect's Chief Executive Officer. "We believe our LEAP technology offers a truly unique, efficient and highly accurate means of isolating rare cells and making them readily available for subsequent functional, proteomic or genetic analyses."

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures